Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Alexandra M. Harrington MD

Alexandra M. Harrington MD

Associate Professor

Institution: Medical College of Wisconsin
Department: Pathology
Division: Administration

Member of the Cancer Center
Member of the Kern Institute


  • Carcinocythemia: A rare entity becoming more common? A 3-year, single institution series of seven cases and literature review. (Ronen S, Kroft SH, Olteanu H, Hosking PR, Harrington AM) Int J Lab Hematol 2018 Sep 14 PMID: 30216684 09/15/2018    
  • Daratumumab in Primary Effusion Lymphoma. (Shah NN, Singavi AK, Harrington A) N Engl J Med 2018 08 16;379(7):689-690 PMID: 30110586 08/16/2018    
  • Flow Cytometry of B-Cell Neoplasms. (Kroft SH, Harrington AM) Clin Lab Med 2017 12;37(4):697-723 PMID: 29128065 11/13/2017       3 Citations
  • CD30 Expression in Monomorphic Posttransplant Lymphoproliferative Disorder, Diffuse Large B-Cell Lymphoma Correlates With Greater Regulatory T-Cell Infiltration. (Hartley C, Vaughan JW, Jarzembowski J, Kroft SH, Hosking P, Harrington AM, Olteanu H) Am J Clin Pathol 2017 Nov 20;148(6):485-493 PMID: 29126177 11/11/2017       1 Citations
  • Evaluation of CD43 expression in non-hematopoietic malignancies. (Batdorf BH, Kroft SH, Hosking PR, Harrington AM, Mackinnon AC, Olteanu H) Ann Diagn Pathol 2017 Aug;29:23-27 PMID: 28807337 08/16/2017    
  • Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic analysis. (Chang JC, Harrington AM, Olteanu H, VanTuinen P, Kroft SH) Ann Diagn Pathol 2016 Dec;25:15-19 PMID: 27806839 11/04/2016       1 Citations
  • Extracavitary primary effusion lymphoma associated with hemophagocytic lymphohistiocytosis. (Epperla N, Harrington AM, Hemauer K, Shah NN) Am J Hematol 2016 Nov;91(11):1161-1164 PMID: 27414752 10/21/2016       1 Citations
  • Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry:  A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes. (Harrington AM, Schelling LA, Ordobazari A, Olteanu H, Hosking PR, Kroft SH) Am J Clin Pathol 2016 Aug;146(2):170-81 PMID: 27413139 07/15/2016       5 Citations
  • Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival. (Dhakal B, D'Souza A, Martens M, Kapke J, Harrington AM, Pasquini M, Saber W, Drobyski WR, Zhang MJ, Hamadani M, Hari PN) Clin Lymphoma Myeloma Leuk 2016 07;16(7):379-86 PMID: 27160644 05/11/2016       2 Citations
  • Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms. (Li H, Hasserjian RP, Kroft SH, Harrington AM, Wheaton SE, Pildain A, Ewalt MD, Gratzinger D, Hosking P, Olteanu H) Am J Clin Pathol 2016 Apr;145(4):538-51 PMID: 27124944 04/29/2016       3 Citations
  • Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer. (Nelson AA, Harrington AM, Kroft S, Dahar MA, Hamadani M, Dhakal B) Bone Marrow Transplant 2016 Feb;51(2):300-2 PMID: 26457913 10/13/2015       14 Citations
  • Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates. (Cogbill CH, Spears MD, Vantuinen P, Harrington AM, Olteanu H, Kroft SH) Int J Lab Hematol 2015 Dec;37(6):797-808 PMID: 26224420 08/01/2015       6 Citations
  • Localized lymph node light chain amyloidosis. (Dhakal B, Harrington AM, Stadler ME, D'Souza A) Case Rep Hematol 2015;2015:816565 PMID: 25922771 PMCID: PMC4398934 04/30/2015    
  • Post-transplant lymphoproliferative disorders. (Singavi AK, Harrington AM, Fenske TS) Cancer Treat Res 2015;165:305-27 PMID: 25655616 02/07/2015       30 Citations
  • Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centers. (Wildes TM, Farrington L, Yeung C, Harrington AM, Foyil KV, Liu J, Kreisel F, Bartlett NL, Fenske TS) Ther Adv Hematol 2014 Feb;5(1):3-12 PMID: 24490019 PMCID: PMC3891289 02/04/2014    
  • CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma. (Olteanu H, Harrington AM, Kroft SH) Am J Clin Pathol 2012 Dec;138(6):867-76 PMID: 23161721 11/20/2012       5 Citations
  • Time and temperature stability of T-cell subsets evaluated by a dual-platform method. (Olteanu H, Schur BC, Harrington AM, Kroft SH) Am J Blood Res 2012;2(2):128-35 PMID: 22762032 PMCID: PMC3384401 07/05/2012    
  • Immunophenotypic stability of CD200 expression in plasma cell myeloma. (Olteanu H, Harrington AM, Kroft SH) Am J Clin Pathol 2012 Jun;137(6):1013-4 PMID: 22586062 05/16/2012       4 Citations
  • A dissection of the CD45/side scatter "blast gate". (Harrington AM, Olteanu H, Kroft SH) Am J Clin Pathol 2012 May;137(5):800-4 PMID: 22523220 04/24/2012    
  • Immunophenotypic stability of Sézary cells by flow cytometry: usefulness of flow cytometry in assessing response to and guiding alemtuzumab therapy. (Vaughan J, Harrington AM, Hari PN, Kroft SH, Olteanu H) Am J Clin Pathol 2012 Mar;137(3):403-11 PMID: 22338052 02/18/2012       13 Citations
  • Flow cytometric analysis of surface light chain expression patterns in B-cell lymphomas using monoclonal and polyclonal antibodies. (Horna P, Olteanu H, Kroft SH, Harrington AM) Am J Clin Pathol 2011 Dec;136(6):954-9 PMID: 22095382 11/19/2011       13 Citations
  • Clinicopathologic analysis of the impact of CD23 expression in plasma cell myeloma with t(11;14)(q13;q32). (Buonaccorsi JN, Kroft SH, Harrington AM, VanTuinen P, Olteanu H) Ann Diagn Pathol 2011 Dec;15(6):385-8 PMID: 21724429 07/05/2011       3 Citations
  • High prevalence of Dapsone-induced oxidant hemolysis in North American SCT recipients without glucose-6-phosphate-dehydrogenase deficiency. (Olteanu H, Harrington AM, George B, Hari PN, Bredeson C, Kroft SH) Bone Marrow Transplant 2012 Mar;47(3):399-403 PMID: 21478917 04/12/2011       8 Citations
  • The immunophenotypic stability of plasma cell myeloma by flow cytometry. (Spears MD, Olteanu H, Kroft SH, Harrington AM) Int J Lab Hematol 2011 Oct;33(5):483-91 PMID: 21470371 04/08/2011       8 Citations
  • Immunophenotypic signatures of benign and dysplastic granulopoiesis by cytomic profiling. (Finn WG, Harrington AM, Carter KM, Raich R, Kroft SH, Hero AO 3rd) Cytometry B Clin Cytom 2011 Sep;80(5):282-90 PMID: 21462309 04/05/2011       6 Citations
  • The unique immunophenotype of double-hit lymphomas. (Harrington AM, Olteanu H, Kroft SH, Eshoa C) Am J Clin Pathol 2011 Apr;135(4):649-50 PMID: 21411790 03/18/2011       18 Citations
  • CD200 expression in plasma cell myeloma. (Olteanu H, Harrington AM, Hari P, Kroft SH) Br J Haematol 2011 May;153(3):408-11 PMID: 21275968 02/01/2011       21 Citations
  • CD23 expression in follicular lymphoma: clinicopathologic correlations. (Olteanu H, Fenske TS, Harrington AM, Szabo A, He P, Kroft SH) Am J Clin Pathol 2011 Jan;135(1):46-53 PMID: 21173123 12/22/2010       17 Citations
  • Multifocal vulvar smooth muscle tumor with an unusual intravascular growth pattern and multiple local recurrences in a 10-year-old child: a diagnostic dilemma. (Harrington A, Bell E, Suchi M, Behmaram B, Uyar D) Pediatr Dev Pathol 2011 May-Jun;14(3):235-9 PMID: 21090988 11/26/2010       1 Citations
  • The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders. (Harrington A, Olteanu H, Kroft S) Am J Clin Pathol 2010 Nov;134(5):749-61 PMID: 20959658 10/21/2010    
  • Immunophenotypic stability of T-cell large granular lymphocytic leukaemia by flow cytometry. (Spears MD, Harrington AM, Kroft SH, Olteanu H) Br J Haematol 2010 Oct;151(1):97-9 PMID: 20636433 07/20/2010       3 Citations
  • Persistent localized bone marrow aplasia after radiotherapy with preserved peripheral counts: a study of 8 cases. (Harrington AM, Currey A, Olteanu H, Kroft SH) Ann Diagn Pathol 2010 Jun;14(3):168-72 PMID: 20471561 05/18/2010       2 Citations
  • Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia. (Olteanu H, Harrington AM, Ramirez S, Kroft SH, Hari P) Br J Haematol 2010 Aug;150(4):480-1 PMID: 20456357 05/12/2010       1 Citations
  • Sperm in peritoneal fluid from a man with ascites: a case report. (Olteanu H, Harrington A, Kroft SH) Cases J 2009 Nov 12;2:192 PMID: 19946502 PMCID: PMC2783147 12/01/2009    
  • Utility of CD56 immunohistochemical studies in follow-up of plasma cell myeloma. (Harrington AM, Hari P, Kroft SH) Am J Clin Pathol 2009 Jul;132(1):60-6 PMID: 19864234 10/30/2009       20 Citations
  • Pencil cells and prekeratocytes in iron deficiency anemia. (Harrington AM, Kroft SH) Am J Hematol 2008 Dec;83(12):927 PMID: 18932191 10/22/2008       3 Citations
  • Iron deficiency anemia, beta-thalassemia minor, and anemia of chronic disease: a morphologic reappraisal. (Harrington AM, Ward PC, Kroft SH) Am J Clin Pathol 2008 Mar;129(3):466-71 PMID: 18285271 02/21/2008       30 Citations
  • Last update: 11/27/2018
    jenkins-FCD Prod-299 9ef562391eceb2b8f95265c767fbba1ce5a52fd6